Importantly, these findings implicate that defects or fluctuations related to the expression of IFN-γ, its receptor, and/or its signaling pathway may underlie the immunopathogenesis of MS as well as other demyelinating inflammatory diseases. This evidence concerns the gene IFNG and myeloid sarcoma.